2025-06-09-Jefferies-邀请—华盛顿之窗_医疗保健行业对特朗普2.0的反应洞察_6页_78kb

Event Invitation for Healthcare Policy Discussion

The document is an equity research report from Jefferies, dated June 9, 2025, focused on biotechnology and healthcare industry reactions to the Trump 2.0 administration. It promotes a 30-minute fireside chat on Tuesday, June 10, 2025, at 10:30 AM ET (3:30 PM UK), featuring analysts from Jefferies, including Michael Yee, Aniket Shah, David Windley, and Akash Tewari, discussing DC policy impacts on healthcare companies, investors, and near-term catalysts. Registration is available via a provided link.

Key details:

• Date and Time: Tuesday, June 10, 2025, 10:30 AM ET / 3:30 PM UK.
• Speakers:
  • Michael Yee, US Biotech Analyst.
  • Aniket Shah, Global Head of Sustainability and Washington Strategy.
  • David Windley, US Managed Care & Pharma Services Analyst.
  • Akash Tewari, US Pharma & Biotech Analyst.
• Topic: Insights on healthcare industry responses to Trump 2.0 policies, including policy effects and catalysts.

The report includes equity research, analyst certifications, investment recommendations (Buy, Hold, Underperform), valuation methodologies, and extensive legal disclosures. It is intended for Jefferies clients only and contains details on potential risks, disclosures, and methodologies used in equity analysis.

More information and registration available via the provided link.